selenium has been researched along with fingolimod hydrochloride in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Z; Jiang, Z; Li, L; Zou, X | 1 |
1 other study(ies) available for selenium and fingolimod hydrochloride
| Article | Year |
|---|---|
Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer.
Topics: Animals; Antineoplastic Agents; BALB 3T3 Cells; Cell Line, Tumor; Delayed-Action Preparations; Female; Fibroins; Fingolimod Hydrochloride; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Rats; Selenium; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2021 |